Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C. Somberg

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
American Journal of Therapeutics|September 9, 2005
Nesiritide: the wrong controversyJohn C Somberg
American Journal of Therapeutics|April 1, 1996
The Cancer MythJohn C. Somberg
American Journal of Therapeutics|February 1, 1995
Dismantling the FDAJohn C. Somberg
American Journal of Therapeutics|January 1, 1995
Editorial: Deferred Consent: Issues In Clinical ResearchJohn C. Somberg
Cardiology|April 1, 2008
Flecainide: safety and efficacyJohn C Somberg
American Journal of Therapeutics|May 10, 2013
A perspective on the support of scientific researchJohn C Somberg
American Journal of Therapeutics|March 19, 2002
The generic conundrumJohn C Somberg
American Journal of Therapeutics|December 4, 2009
New advances and new questions in cardiovascular therapeuticsJohn C Somberg
American Journal of Therapeutics|November 11, 2005
An opportunity to distance the FDA from Washington politicsJohn C Somberg
American Journal of Therapeutics|November 9, 2002
Biologic problemsJohn C Somberg
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
American Journal of Therapeutics|September 9, 2005
Nesiritide: the wrong controversyJohn C Somberg
American Journal of Therapeutics|April 1, 1996
The Cancer MythJohn C. Somberg
American Journal of Therapeutics|February 1, 1995
Dismantling the FDAJohn C. Somberg
American Journal of Therapeutics|January 1, 1995
Editorial: Deferred Consent: Issues In Clinical ResearchJohn C. Somberg
Cardiology|April 1, 2008
Flecainide: safety and efficacyJohn C Somberg
American Journal of Therapeutics|May 10, 2013
A perspective on the support of scientific researchJohn C Somberg
American Journal of Therapeutics|March 19, 2002
The generic conundrumJohn C Somberg
American Journal of Therapeutics|December 4, 2009
New advances and new questions in cardiovascular therapeuticsJohn C Somberg
American Journal of Therapeutics|November 11, 2005
An opportunity to distance the FDA from Washington politicsJohn C Somberg
American Journal of Therapeutics|November 9, 2002
Biologic problemsJohn C Somberg
Pageof 13